| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Blood Sugar Articles
A professional doctors' group has petitioned the Food and Drug Administration to require that Avandia's warning label include a statement that a low-fat vegan diet is a safer, more effective approach to lowering blood sugar levels than the drug itself.
The Physicians Committee for Responsible Medicine says that the benefits of the diet, which include a lowering of blood pressure and cholesterol levels, weight loss and the prevention - even reversal - of heart disease, should be made clear to Avandia users.
The group's request comes in the wake of a recent FDA decision to require a "black-box" warning on Avandia alerting users to the increased risk of heart attacks. Researchers claim that 13,000 instances of heart attack and heart failure in the United States can be attributed to the drug.
Avandia is the brand name for rosiglitazone, part of the thiazolidinedione class of drugs used to control blood glucose. GlaxoSmithKline introduced the drug in 1999.
Source: Physicians Committee for Responsible Medicine
Categories: Blood Sugar, Diets, Type 2 Issues
Sep 22, 2008 -
Email to a Friend
Send a link to this page to your friends and colleagues.